Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
43.60
+3.02 (7.44%)
Jan 21, 2025, 4:00 PM EST - Market closed
Veracyte Market Cap
Veracyte has a market cap or net worth of $3.38 billion as of January 21, 2025. Its market cap has increased by 78.00% in one year.
Market Cap
3.38B
Enterprise Value
3.11B
1-Year Change
78.00%
Ranking
Category
Stock Price
$43.60
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $3.38B, an increase of 1,132.76%. That is a compound annual growth rate of 25.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.14B | 2.47% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |